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Abstract. Plasmodium falciparum malaria parasites
invade human erythrocytes by means of a parasite re-
ceptor for erythrocytes, the 175-kD erythrocyte bind-
ing antigen (EBA-175) . Similar to invasion efficiency,
binding requires N-acetylneuraminic acid (Neu5Ac)
on human erythrocytes, specifically the glycophorins.
EBA-175 bound to erythrocytes with receptor-like spec-
ificity and was saturable. The specificity of EBA-175
binding was studied to determine if its binding is in-
fluenced either by simple electrostatic interaction with
the negatively charged Neu5Ac (on the erythrocyte sur-
face) ; or if Neu5Ac indirectly affected the conforma-
tion of an unknown ligand, or if Neu5Ac itself in spe-
cific linkage and carbohydrate composition was the
primary ligand for EBA175 as demonstrated for hemag-
glutinins of influenza viruses. Most Neu5Ac on human
erythrocytes is linked to galactose by a2-3 and a2-6
linkages on glycophorin A . Soluble Neu5Ac by itself
in solution did not competitively inhibit the binding of
F invasion of malaria parasites into human erythrocytes
were prevented, the malaria life cycle would be inter-
rupted and disease prevented. Thus, considerable effort
has gone into understanding the molecular basis of parasite
invasion into erythrocytes. Invasion requires recognition by
the parasite of the appropriate host cell during one or more
steps thatincludemerozoiteattachment, apical reorientation,
apical junction formation, release of the contents of api-
cal organelles, and entry into the erythrocyte (16, 21). The
glycophorins, major sialoglycoproteins present on the erythro-
cyte surface, appear to be responsible for the sialic acid-
dependent invasion into erythrocytes by Plasmodium fal-
ciparum malaria merozoites (10, 11, 16, 18, 29, 30, 33-36).
Recognition ofsialic acid-containing receptors on the erythro-
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EBA-175 to erythrocytes, suggesting that linkage to an
underlying sugar is required for binding in contrast
to charge alone. Binding was competitively inhibited
only by NeuSAC(a2-3)Gal-containing oligosaccharides.
Similar oligosaccharides containing Neu5Ac(a2-6)Gal-
linkages had only slight inhibitory effects. Binding in-
hibition assays with modified sialic acids and other sac-
charides confirmed that oligosaccharide composition
and linkage were primary factors for efficient binding.
EBA-175 bound tightly enough to glycophorin A that
the complex could be precipitated with an anti-glyco-
phorin A monoclonal antibody. Selective cleavage of
O-linked tetrasaccharides clustered at the NH2 termi-
nus of glycophorin A markedly reduced binding in
inhibition studies. We conclude that the Neu5Ac(a2,3)-
Gal- determinant on O-linked tetrasaccharides of gly-
cophorin A appear to be the preferential erythrocyte
ligand for EBA-175.
cyte surface by malaria receptors might be analogous to in-
fluenza virus entry into host cellsby means ofthe hemagglu-
tinins which bind with stereospecificity to sialic acid-capped
oligosaccharides (46).
Erythrocytes with modifications or deficiencies in the
glycophorins show marked reductions in invasion efficien-
cies by Plasmodium falciparum merozoites. Invasion into
Ena- erythrocytes (deficient in glycophorin A) (29, 33),
MkM1 erythrocytes (deficient in glycophorins A and B)
(18), Tn erythrocytes (missing the terminal sialyl and galac-
tosyl residues of the O-linked oligosaccharide structures on
glycophorin [9]) (5, 30), and Cad erythrocytes (with an ad-
ditional N-acetylgalactosamine residue on the O-linked
oligosaccharides) (5) showed reduced invasion efficiencies.
Similarly, enzymatic modification of erythrocyte surface
molecules by either trypsin or neuraminidase, treatments
that have a direct effect on the integrity of the glycophorins,
render the erythrocyte resistant to invasion (4, 16, 18, 33).
In parallel experiments, erythrocytes with modifications
or deficiencies in the glycophorins also had marked reduc-
tions in the binding of the 175-kD erythrocyte binding anti-gen of Plasmodiumfalciparum (EBA175),' a receptor ap-
parently needed for efficient invasion (4, 16, 32) . EBA-175
is a protein that is released from merozoites into culture su-
pernatants aftertheir release from schizont-infected erythro-
cytes in the absence of target erythrocytes. Results from
previous studies have demonstrated that EBA-175 acts with
receptor-like specificity and requires sialic acids on the
erythrocyte ligand for binding (4, 32) . Similarly, the binding
of EBA-175 to invasion-competent erythrocytes correlates
closely with merozoite invasion efficiency (4, 32). Further
evidence that ERA-175 is a receptor facilitating invasion into
erythrocytes was obtained by Sim et al., who reported that
antibodies raised against the peptide 4 region ofEBA-175 are
effective in inhibiting both the binding of EBA-175 to
erythrocytes and merozoite invasion in vitro (41).
Although a direct interaction between the glycophorins
and EBA-175 has not beendemonstrated, thebinding charac-
teristics of EBA-175 suggested that EBA-175 binds to the
glycophorins, ofwhich glycophorin A is the most abundant.
Glycophorin A contains 1 N-linked complex chain and 15
O-linked tetrasaccharides, 6 of which are on immediately
adjacent serine and threonine residues and 11 of which are
clustered within the first 30 amino acids at the NH2 ter-
minus. The O-linked tetrasaccharides have the following
structure:
Neu5Ac(a2-3)Gal(ßl-3)Ga1NAc(a) -serine or threooine
i(a2-6)
Neu5Ac
These oligosaccharides make up -60% of the molecular
weight of glycophorin A and are each capped with N-acetyl-
neuraminic acid (Neu5Ac), accounting for X60 % ofthetotal
sialic acid at the surface of the human erythrocyte (2).
Several characteristics of ligand-receptor interactions re-
mainedto be studied: saturability ofbinding, competitive in-
hibition ofbinding with small ligands, ligand stereospecificity,
and the demonstration of direct interaction between the
ligand and the receptor by immunoprecipitation as a com-
plex. Because sialic acids such as Neu5Ac impart a negative
charge and are known to affect binding through electrostatic
forces as well as cause conformational changes of adjacent
molecules (40), it was of particular interest to show that
charge alone did not account for binding and that a small
ligand containing Neu5Ac did itselfcompete for erythrocytes
in binding EBA175. In this study we describe the carbohy-
drate specificities and structural requirements for binding of
EBA175 as well as the interactions ofthis malaria lectin with
the 0-linked tetrasaccharide chains of glycophorin A.
Materials andMethods
Materials
All materials were obtained as follows: trypsin, PMSF, N-glycolylneura-
minic acid (Neu5Gc), neuramin(a2-3) lactose (Neu5Ac(a2-3)Gal(ßl-4)Glc),
neuramin (a2-6)lactose (Neu5Ac(a2-6)Gal(ßl-4)Glc), and glycophorin A
from Sigma Chemical Co. (St. Louis, MO); N-acetylneurarninic (NeuAc),
glucosamine, galactosamine, N-acetylglucosamine, N-acetylgalactosa-
1. Abbreviations used in this paper: DST, disialyllacto-N-tetraose, Neu-
5Aca2-3Galßl-3 (Neu5Aca2-6) GIcNAcßl-3Galß1-4Glc. ERA-175, erythro-
cyte binding antigen-175; Endo F, endo-ß-N-acetylglucosaminidase F;
SRBC, schizont-infected erythrocytes; Lac, lactose, galactoseßl-4glucose;
LST a, sialyllacto-N-tetraose a, Neu5Aca2-3Gaiß1-3G1cNAcß1-3Galß1-
4Glc; LST b, sialyllacto-N-tetraose b, Galßl-3-(Neu5Ac(x2-6) G1cNAcß1-
3Galß1-4Glc; NDV, Newcastle disease virus; Neu5Ac, N-acetylneuraminic
acid; Neu5Ac-Lac, neuramin-lactose; Neu5Gc, N-glycolylneuraminic acid.
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mine, chitobiose, chitotriose, and chitotetraose from Supelco Inc. (Belle-
fonte, PA); Vibrio cholerae neuraminidase (500 U ml-) and FBS from
Gibco Laboratories (Grand Island, NY); endo-ß-N-acetylglucosantinidase
F (Endo F) from BoehringerMannheim Corp. (Indianapolis, IN); F-50 sili-
con fluid from General Electric; goat anti-mouse IgG (H+L) Sepharose
from Cappel Laboratories (Malvern, PA); protein A-Sepharose from Phar-
macia FineChemicals (Piscataway, NJ); sialyllacto-N-tetraoseaandb (LST
aandb) anddisialyllacto-N-tetraose(DST) from BioCarb chemicals (Lund,
Sweden). Immune Aotus serum (Ao29) was obtained from monkeys im-
munizedagainst theMalayan Camp strain ofPlasmodiumfalciparum (6, 7).
Anti-glycophorin A hybridoma supernatants from monoclonal antibody
453.1.1 (17) were generously supplied by T. J. Hadley (University ofLouis-
ville School of Medicine, Louisville, KY) and S. Futrovsky (Walter Reed
Army Institute of Research, Washington, DC). Tn and M1Mk erythrocytes
were donated by Dr. L. H. Miller (Laboratory of Parasitic Diseases, Na-
tional Institutes of Health, Bethesda, MD. Newcastle disease virus (NDV),
strain Bl, was graciously provided by Dr. T. G. Morrison (University of
Massachusetts Medical Center, Worcester, MA).
Culture ofParasites
Cloned Camp strain Plasmodiumfalciparum parasites (Malaysia) were cul-
tured and synchronized as described (27, 44). Schizont-infected erythro-
cytes (SRBC) were isolated by banding on Percoll gradients (1). SRBC were
washedtwice in medium containing 10% FBS and cultured for 16 h at37°C
at a cell density of 1.5 x 10 Ml-' with or without [3H]isoleucine in 10%
FBS as describedpreviously (4). At theend ofthe incubationperiod, during
which >95% of schizonts ruptured, the cell pellets and supernatants were
collected by centrifugation at 300 g per min per mm-1 (27) and stored at
-s0°C.
Enzymatic TreatmentsofIntact Erythrocyteand
Glycophorin A Modifications
Treatment of intact human erythrocytes with 50 U ml-' Vibrio cholerae
neuraminidase or 1.0 mg ml-' trypsin was performed as described (4).
Erythrocytes were treated with NDV for 60 min at 37°C at a 5% Hct and
10 jig ml-' of viral protein. Treatment of erythrocytes with Endo F was
performed with 3.0 U ml-' in PBS, pH 7.0, at a 5% Hct overnight at 37°C.
Analysis of EBA175 binding to these enzymatically treated cells was per-
formed as described below. Deglycosylation ofthe alkali-labile oligosaccha-
rides of glycophorin A was carried out at 1 mg ml-' in 0.1 N NaOH at
37°C for72 h(42). Vibriocholeraeneuraminidasetreatment ofglycophorin
A (1 mg ml') was performed with 50 U ml-' ofthe enzyme in 0.05 M so-
dium acetate buffer, pH 5.5, 0.150 M NaCl, and 0.009 mM CaC12 over-
night at 37°C. It was necessary to add 10% FBS to neuraminidase-treated
glycophorin A samples before assaying forEBA-175 binding to quench any
remaining neuraminidaseactivity. Glycophorin A was treated with NDV as
above in the same buffer containing 5 ug ml-' of viral protein. Viral parti-
cles were pelleted by centrifugation after the incubation period. A control
blank containing only NDV and treated similarly was included to control
for any residual NDV neuraminidase activity which may affect EBA-175
binding by modification of erythrocyte-bound glycophorin A. Glycophorin
A at a concentration of 0.3 mg ml-' was treated with 3.0 U ml-' Endo F
in 0.075 M sodium acetate, pH 7.0, overnight at 37°C. Treated glycophorin
A samples were concentrated and resuspended in PBS twice using Centri-
con 10 filtration devices (Amicon, Beverly, MA) and adjusted to 1 mg
ml-' before assaying for EBA175 binding inhibition. Molar concentrations
at which binding inhibition is observed are based on the molecular weight
of glycophorin A2.
Pleriodate Oxidation/Borohydride Reduction
ofIntact Erythrocytes
Human erythrocytes were washed several times in serum-free culture
medium and resuspended at a 5% Hct in PBS containing the appropriate
concentration of IOá. The suspension was incubated on ice for 15 min
(13) . Erythrocytes were pelleted and washed twice with 15 ml of 0.1 M
glycerol in PBS followed by an additional wash in PBS. Erythrocytes were
subsequently treated with NaBH4 (1 mg ml-') in PBS at a 5% Her for 30
min at room temperature. After three washes in PBS, erythrocytes were
diluted 50% in serum-free medium and used in binding assays.
Isolation ofERA175
Afnity-purifiedfromErythrocytes
andBindingInhibitionAssays
Culture supernatants metabolically labeled with [3H]isoleucine were pre-
902pared as described above containing 10% FBS . FBS was used in place of
human serum to eliminate antibodies that might react with modified eryth-
rocyte surface antigens. No differences were observed in the binding of
EBA-175 in the presence of either FBS or human serum . Fresh, human
erythrocytes were washed several times in serum-free medium. EBA-175
affinity-purified from erythrocytes was prepared as described previously
(19, 32) . For binding inhibitionassays conducted in the presence ofpurified
saccharides, oligosaccharides, or protein, 0.075 ml ofthe appropriate sub-
stance in PBS, pH 7.0, was combined with 0.025 nil ofculture supernatant
(3.75 x los schizont equivalents) . Concentrations were based on the 0.10
ml final volume. This reagent was then added to 0.10 ml ofpacked erythro-
cytes (1 .0 x 10~ and incubated and processed as described (32) . After
SDS-PAGE and fluorography, EBA-175 binding was quantified by scanning
laser densitometry ofthe fluorographs using anLKB 2022 Ultrascan laser
densitometer (LKB Instruments, Inc ., Gaithersburg, MD) .
SDS-PAGE
Discontinuous SDS-PAGE was performed on 7.5% (1.5 mm) SDS-
polyacrylamide gels by the method ofLaemmli (25) . For fluorography, gels
were treated withEN3HANCE (New England Nuclear, Boston, MA) and
exposed to Kodak XAR-2 film at -80°C (3, 26) . Gels stained for the pres-
ence of sialic acid were fixed overnight in 7.5% acetic acid. The gels were
then treated with 0.040 M periodic acid for 2 h at 37°C followed by exten-
sive washing for 1 h with distilled water, incubated with ice-cold resorcinol
reagent (54 .5 mM resorcinol, 0.25 mM CuSO4, 5.2 M HCl) for 15 min,
heated at 60°C for 10 min, and slowly heated to 80°C until maximum color
developed .
Immunoprecipitation
For the immunoprecipitation of the glycophorin A/EBA-175 complex, cul-
ture supernatants were incubated with erythrocytes as describedabove . The
erythrocytes were then pelleted, washed twice in serum-free medium, and
lysed with0.5 ml PBS containing 1% Triton X-100and0.002M PMSF. The
solubilized cells were then reacted overnight at 4°C with either 0.5 ml of
mAb 453 ascites diluted 1:250 or 0.5 nil of immune Aotus serum diluted
1:250 and precipitated as previously described (28) . After SDS-PAGE,
precipitated antigens were detected by fluorography (3, 26) .
Results
BindingofERA-175
EBA175 is the major malaria antigen isolated from culture
supernatants which binds to and is eluted from normal hu-
man erythrocytes with high salt buffer (Fig. l, lane b) (4, 19,
32, 41) . As described here and elsewhere (4, 32), the binding
of EBA-175 is a sialic acid-dependent event and is inhibited
by pretreatment of erythrocytes with neuraminidase and
trypsin (Fig. 1, lanes c and d, respectively) . When culture
supernatants were incubated with MkMk orTn erythrocytes,
no EBA-175 binding was detected (Fig . 1, lanes e and f,
respectively) . In contrast, pretreatment of intact erythro-
cytes with EndoF had no detectable effect on the binding of
EBA-175 when compared with untreated erythrocytes (Fig.
1, lane h) .
Immunoprecipitation oftheEBA175IGlycophorinA
Complexfrom Erythrocytes
The direct interaction between erythrocyte-bound glycopho-
rinA and EBA-175 was shown through immunoprecipitation
of the receptor-ligand complex (Fig . 2) . In the presence of
either malaria-immune Aotus serum (Fig . 2, lanes a and b)
or mAb 453 specific for glycophorin A (17) (Fig. 2, lanes
c and d), EBA175 was inununoprecipitated from lysates of
binding-competent erythrocytes (Fig. 2, lanes a and c) . Nei-
ther antibodyprecipitated detectable levels ofEBA-175when
erythrocytes were pretreated with Vibrio cholerae neur-
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Figure 1. The binding of EBA-175 to human erythrocyte isolates .
Culture supernatants metabolically labeled with [ 3H]isoleucine
were prepared from the Camp strain ofPlasmodium falciparutn as
described in Materials and Methods . Erythrocytes were incubated
with supernatants, separated by centrifugation through F-50 silicon
fluid, and eluted in high salt buffer, and the eluate was subjected
to SDS-PAGE as described in Materials and Methods . Shown here
are eluates from binding assays using erythrocytes characterized for
their modification and expression of glycophorins A and B . Lane
a, total culture supernatant ; lane b, untreated human erythrocytes ;
lane c, trypsin-treated human erythrocytes ; lane d, neuraminidase-
treated erythrocytes ; lane e, MkMk erythrocytes ; lannf Tn erythro-
cytes ; lane g, untreatederythrocytes; lane h, erythrocytespretreated
with Endo F.
aminidase before incubation with culture supernatants (Fig .
2, lanes b and d) . The isolation of an EBA-175/glycophorin
A complex provides direct evidence that EBA-175 recognizes
and binds to sialic acid-containing determinants on glyco-
phorinA and supports previous studies on the identity of the
erythrocyte ligand .
BindingofERA-175 to Erythrocytes and
Specific Elution
EBA-175 is released into culture supernatants during schiz-
ont rupture (4, 32) . The binding of EBA-175 from superna-
tants to intact human erythrocytes is a saturable event (Fig .
3 A) and is linear at dilute concentrations of these superna-
tants. The smooth shape of the binding curve is consistent
with a single class ofhigh affinity binding sites. The binding
of radiolabeled EBA-175 to erythrocytes is also competi-
tively inhibited with increasing concentrations of unlabeled
cultured supernatants (data not shown) .
903Figure 2 . Isolation of the EBA-175/glycophorin A complex from
erythrocytes. Normal (lanes a and c) and neuraminidase-treated
(lanes b and d) human erythrocytes were incubated with [3H]iso-
leucine-labeled culture supernatants, pelleted, washed, and lysed
with 1 % Triton X-100 in PBS as described in Materials and Meth-
ods . Immunoprecipitations of the erythrocyte lysates with immune
Aotus serum (Ao29) ormAb 453 were performed as also described
in Materials and Methods . Samples were separated by SDS-PAGE
and detected by fluorography. Lanes a and b, erythrocyte lysates
immunoprecipitated with immune Aotus serum ; lanes c and d,
erythrocyte lysates immunoprecipitated with mAb 453 .
Erythrocyte-bound EBA-175 can be efficiently eluted with
1MNaCl (19, 32) . Under isotonic conditions, however, only
a small percentage of the bound protein freely dissociated
(Fig . 3 B) . Although the binding activity of EBA-175 is de-
pendent on the presence of terminal sialic acid residues, free
Neu5Ac was unable to elute EBA-175 (Fig. 3 B) . In contrast,
the effectiveness of Neu5Ac(o12-3)Lac (Fig . 3 B) in eluting
bound EBA-175 was similarto high salt and suggested amore
defined ligand specificity for binding and elution .
While it has been well established that pretreatment of in-
tact erythrocytes with Vibrio cholerae neuraminidase abro-
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gates EBA-175 binding, this bacterial enzyme under optimal
conditions will cleave all terminal Neu5Ac (8) . NDV, how-
ever, is specific for (a2-3)-linked Neu5Ac (8) . As shown in
Table I, pretreatment ofintact erythrocytes with either neur-
aminidase results in a similar inhibition of EBA-175 binding .
These results suggested that terminal Neu5Ac(a2-3)- resi-
dues are required for EBA-175 binding and complement re-
sults observed with Neu5Ac(a2-3)Lac in the elution of eryth-
rocyte-bound EBA-175.
E ffectsofSoluble GlycophorinA on theBindingof
ERA-175 to Erythrocytes
GlycophorinA was treated either with Vibrio cholerae neur-
aminidase or NDV to remove terminal Neu5Ac residues
alone ; with mild alkali to eliminate the O-linked tetrasaccha-
rides en bloc (42), or with Endo F to enzymatically remove
the lone N-linked complex chain (43) . SDS-PAGE illustrat-
ing the expected electrophoretic patterns of the modified
glycophorins is shown in Fig . 4, A andB (13) . These soluble
glycophorins were subsequently assayed for their ability to
inhibit the binding of EBA-175 to erythrocytes . Untreated
glycophorin A was effective in inhibiting the binding ofEBA-
175 to erythrocytes by 71 and 89% ofcontrols that contained
no additions (Fig . 4 C) at concentrations of 4 .0 and 8.0 pM
of purified protein . Similarly, glycophorin A pretreated with
Endo F also retained its inhibitory effects on binding (Fig .
4 C) . Neither the neuraminidase- nor alkali-treated glyco-
phorin A samples, however, had any significant inhibitory
activity at the same concentrations .
Inhibition ofERA-175 Bindingto Erythrocytes in the
Presence ofSolubleSaccharides
The ligand specificity for EBA-175 binding, was defined by
the addition ofsolublemono- and oligosaccharides to culture
supernatants to assess their potential to competitively inhibit
the binding of EBA-175 to erythrocytes. As shown in Table
II, the most potent inhibitors of EBA-175 binding were Neu-
5Ac(a2-3)Lac and Neu5Gc. Binding was slightly affected
when assayed in the presence of G1cNAc, with increasing in-
hibition observed with oligomers of G1cNAc such as chito-
tetraose . This suggests a binding specificity comparable to
the lectin of Tritucum vulgaris whose binding is specific for
NeuAc and G1cNAc and its oligomers (31) .
Inhibition by Neu5Ac(a2-3)Lac was concentration depen-
dent and inhibited binding by 76 and 90% of control binding
at concentrations of 25 and 50 mM, respectively (Fig . 5) .
The degree of binding inhibition observed in the presence of
Neu5Ac-Lac was dependent on the sialyl-galactosyl- link-
age . The inhibition seen with the a2-6 isomer, Neu5Ac(a2-
6)Lac, was never greater than 25-35% at 50 mM . Free
Neu5Ac and lactose had no significant inhibitory effects on
binding at concentrations as high as 50 mM .
The individual contributions of the (a2-3)- and (a2-6)-
linked Neu5Ac residues of the tetrasaccharides of glycopho-
rin A on the binding of EBA-175 were studied and compared
using the purified oligosaccharides LST a, LST b, and DST
in binding inhibition assays (Table III) . These oligosaccha-
rides reflect the spatial orientation and linkages of the two
Neu5Ac residues expressed on the O-linked tetrasaccharides
ofnative glycophorinA . When used in binding inhibition as-
says the results are consistent with those in the presence of
904Neu5Ac-Lac. Oligosaccharides containing the terminal Neu-
5Ac(a2-3)galactosyl- sequence (LST a and DST) were inhib-
itory (Table II). LST b, containing only the (a2-6)-linked
Neu5Ac, was less effective in inhibiting the binding of EBA-
175 to erythrocytes, similar to the results seen with Neu-
SAc(a2-6)Lac.
EffectsofCarbohydrate Presentation on theBinding
ofERA-175 to Erythrocytes
The relative inhibitory concentrations of Neu5Ac(a2-3)Gal-
Table L Neuraminidase Specificity andEBA-175 Binding
* Erythrocytes at a 5% Hct were treated with either 50 U ml-' Vibrio choler-
ae neuraminidase or 10 pg ml-1 NDV, strain 131, in serum-free medium for
60 min at 37°C. Erythrocytes were then washed three times in medium con-
taining 10% FBS and assayed for ERA-175 binding as described in Materials
and Methods.
t Relative binding of EBA-175 wasquantified by scanning laser densitometry
of fluorographs using an LKB 2022 Ultrascan laser densitometer and are
reported as a measure of control binding.
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Figure 3. Binding ofEBA-175 to erythrocytes. (A) Saturationcurve for EBA-175 binding to intact erythrocytes. Culture supernatants meta-
bolically labeled with [3H]isoleucine prepared at a concentration of 4 x 107 schizont equivalents ml-1, were diluted with complete me-
dium to the indicated concentrations in a final volume of0.1 ml, incubated with 1.0 x 109 erythrocytes, and assayed for EBA-175 binding
as described in Materials and Methods. After separation by SDS-PAGE and detection by fluorography, relative binding was quantified by
scanning densitometry of the autoradiographs. (B) Selective elution oferythrocyte-bound EBA175. Binding assays using 0.1 ml metaboli-
cally labeled culture supernatants (1.5 x 107 schizonts ml-1) and 1.0 x 109 erythrocytes were conducted as described above. EBA-175
was then eluted with PBS, or 1 M NaCl, Neu5Ac, or Neu5Ac(a2-3)Lacin 0.02 nil in PBS. All elutions were for 20 min at room temperature
except for 1 M NaCl, whichwas for 10 min. After separation by SDS-PAGE and detection by fluorography, relative elution was quantified
by scanning densitometry of the autoradiographs.
as it is expressed either on glycophorin A, fetuin, or freely
soluble Neu5Ac(a2-3)Lac were compared. Fetuin contains
three nonadjacent O-linked tetrasaccharide structures other-
wise identical in composition and linkage to the clustered
tetrasaccharides of glycophorin A (42). Whereas the effec-
tive concentration of glycophorin A-bound NeUSAC(a2-
3)Gal- associated with 50% inhibition of EBA-175 binding
was found at 10-5 M, it required two to three orders of
magnitude more Neu5Ac(a2-3)Gal- on fetuin to achieve the
same effect (Fig. 6) . Fetuin was only slightly more effective
than NeuSAC(ca2-3)Lac (Fig. 6) . Neuraminidase-treated fe-
tuin with not inhibitory (data not shown).
E ffects ofPeriodate 7lreatment ofIntact Erythrocytes
Human erythrocytes were treated with periodate followed by
borohydride reduction under conditions previously shown to
cleave the exocyclic side chain of sialic acids. These cells
were then examined for their potential to bind EBA-175.
Erythrocytes treated with periodate concentrations of 0.1-
2.0 mM bound EBA-175 as well as untreated erythrocytes
(Thble IV) .
Discussion
The means needed to effectively prevent the invasion of Plas-
modiumfalciparum merozoitesinto erythrocytes requires an
understanding of those malarial receptors that participate in
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NDV 0.09 Neu5Ac(a2-3)-Figure 4. Inhibition of EBA
175 binding to erythrocytes
by glycophorin A . (A and B)
Chemicaland enzymatic treat-
ments of glycophorinA . Sam-
ples were separated by a SDS-
PAGE on a l0-20Î gradient
gel and autoradiographed (A)
or stained for the presence of
Neu5Ac (B) as described in
Materials and Methods. (A)
Purified I'll-glycophorin A:
untreated(lane a) ; Vibrio chol-
erae neuraminidase-treated
(lane b) ; NDVtreated (lane
c) ; mild alkali-treated (lane d) ; and Endo F-treated (lane e) . (B)
Untreated (lanea) ; Vibrio choleraeneuraminidase-treated (laneb) ;
mild alkali-treated (lane c) ; and Endo F-treated (lane d) . (C) Ef-
fects of EBA175 binding to erythrocytes by modified glycopho-
rin A . Binding assays were conducted with [ 3H]isoleucine-labeled
culture supernatants as described in Materials and Methods in the
presence of increasing concentrations of untreated (o), neuramini-
dase-treated (Vibrio cholerae) (o), NDVtreated (o), mild alkali-
treated (A), or Endo F-treated (e) . After separation bySDS-PAGE
and detection by fluorography, binding was quantified by scanning
densitometry ofthe autoradiographs and expressed as a percentage
of control binding as described in Materials and Methods. Values
for NDVtreated glycophorinA were obtained by subtracting densi-
tometry readings ofcontrol blanks which contained equivalent vol-
umes ofNDV but no glycophorin A to control for residual NDV
neuraminidase activity unquenched by FBS, but which will affect
erythrocyte-bound glycophorin A .
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the attachment and invasion process and the ligands on the
host cell with which they recognize . In this study we describe
the carbohydrate determinants required for efficient binding
of EBA-175, a lectin-like malaria receptor. This protein has
previously been shown to be an important component in the
erythrocyte invasion process by Plasmodium falciparum
merozoites . The binding of EBA-175 is dependent on the
presence of sialic acid-containing determinants on the eryth-
rocyte surface which are sensitive to cleavage by pretreat-
ment with either neuraminidase or trypsin . Such pretreat-
ments abrogate EBA-175 binding (4, 32), prevent merozoite
invasion in vitro (4, 16, 30), and can be shown to have a di-
rect effect on the integrity of the N112-terminal domain of
glycophorins A and B in which 11 of 15 O-linked tetrasac-
charides and the lone N-linked complex chain are expressed
within the first 30 amino acids . Similarly, the binding of
EBA-175 reflects the same degree of correlation that exists
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Table It. Binding Inhibition ofEBA-175 to Erythrocytes
* The final concentrations of all oligosaccharides tested were 50 mM and the
culture supernatants were adjusted to pH 7.0 before mixing with erythrocytes .
t Binding assays were conducted as described in Materials and Methods .
Relative binding ofEBA-175 was quantified by scanning laser densitometry of
fluorographs using anLKB2022 Ultrascanlaser densitometer and are reported
as a measure of control binding .
between merozoite invasion and glycophorin presentation on
the erythrocyte surface . Confirmation of the direct interac-
tion of EBA-175 with sialic acid-containing determinants of
glycophorin A on intact erythrocytes was achieved through
coprecipitation ofthe receptor-ligand complex with the anti-
glycophorin mAb 453 (Fig . 2), while the absence of binding
to neuraminidase-treated erythrocytes was in agreement
with results seen here and elsewhere (Fig . 1, lane d ; Fig . 2,
and references 4 and 32) . Furthermore, the absence of bind-
ing to glycophorin A- and B-deficient MkNP erythrocytes
(Fig . 1, lane e) suggests that sialic acid elsewhere on the
erythrocyte surface is not sufficient for binding EBA175.
Evidence for the binding of EBA-175 to the alkali-labile
tetrasaccharides of glycophorin A is provided by the results
obtained on the effects of soluble, modified glycophorin A
in binding inhibition assays . The inhibition of binding seen
in the presence of glycophorin A is lost if the glycoprotein
is pretreated with either Vibrio cholera neuraminidase or
NDV to remove terminal NeuSAC(a2-3)- residues or with
mild alkali to remove the O-linked tetrasaccharide chains be-
fore assaying for inhibition .
While electrostatic interactions due to the presence of the
negatively charged C-1 carboxyl group ofNeu5Ac may con-
tribute to the binding of EBA-175 to some degree, competi-
tive binding inhibition assays with soluble oligosaccharides
indicated that saccharide composition and linkage to an un-
derlying sugar are greater factors in binding efficiency. This
is in apparent contrast to the reported effects ofcharge on the
invasion of erythrocytes by merozoites (12) .
The binding ofEBA175 to erythrocytes is inhibited by the
presence of DST, LST a, and NeuSAc(a2-3)lactose . These
oligosaccharides reflect to a large extent the composition,
linkage, and spatial orientation of the NeuAc and Gal-
residues of the alkali-labile tetrasaccharides of glycophorin
A . The ability of Neu5Ac(a2-3)Lac, LST a, and DST to in-
hibit the binding of ERA-175 to erythrocytes, when con-
trasted with those seen with Neu5Ac(a2-6)Lac and LST b,
suggested that the terminal carbohydrate sequence Neu5Ac-
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Addition* Relative binding$
None 1 .0
Neu5Ac 0.95
Neu5Gc 0.05
N-Acetylneuramin(a2-3) lactose 0.15
N-Acetylneuramin(a2-6) lactose 0.70
Lactose 1 .05
Galactose 0.92
Galactosamine 1.09
Glucosamine 0.91
N-Acetylgalactosamine 0.94
N-Acetylglucosamine 0.80
Chitobiose 0.94
Chitotriose 0.86
Chitotetraose 0.44
Raffinose 1.05
Stachyose 0.94Figure S. Inhibition of EBA-
175 binding to erythrocytes
in the presence of Neu5Ac-
Lac. Binding assays were con-
ducted with [3H]isoleucine-
labeled culture supernatants
as described in Materials and
Methods with increasing con-
centrations of the indicated
saccharides. After separation
by SDS-PAGE and detection
by fluorography, binding was
quantified by scanning densi-
tometry ofthe autoradiographs
and expressed as a percentage of control binding as described in
Materials and Methods. Neu-5Ac(a2-3) lactose (o), NeuSAc(a2-6)
lactose (o) lactose (o), and Neu5Ac (A).
(a2-3)Gal- was the primary ligand required for efficient bind-
ing. The modest effects of the (cat, 6)-linked Neu5Ac resi-
dues of LST b may be a consequence of the greater degrees
of freedom it possesses in solution. When protein-bound,
this ligand may be more restricted and remain relatively in-
accessible to the binding domain of EBA-175 as in the native
glycophorin A molecule. This is supported by results ob-
tained with neuraminidase treatment. NDV will not cleave
Neu5Ac(a2-6)- residues (8), while its action on intact eryth-
rocytes to eliminated EBA-175 binding. Similarly, only the
NeuSAC(a2-3)-linked residues of the O-linked tetrasaccha-
rides of glycophorin A on intact erythrocytes are susceptible
to the action of Vibrio cholerae neuraminidase. The inability
to liberate the (ca2-6)-linked Neu5Ac ofthese same tetrasac-
charides is attributed to steric hindrance (14). This steric
hindrance, as well as intrinsic lower affinity, may severely
limitthe role ofa 2-6-linked Neu5Ac on glycophorinforbind-
ing EBA-175.
While the data presented here clearly suggest that the
Neu5Ac(a2-3)Gal- determinant is necessary for binding,
comparison ofresults obtained from competitive binding in-
hibition studies with glycophorin A, fetuin, and NeUSAC(a2-
3)Lac indicate that this determinant alone is not sufficientfor
the high affinity binding observed with EBA-175 and glyco-
phorin A. Oligosaccharide density and presentation of the
determinants of glycophorin A may be factors that influence
the higher degree of binding. Fetuin, which contains only
three nonadjacent O-linked oligosaccharide structures other-
wise identical to the 15 clustered on glycophorin A, and
Orlandi et al. Binding Specificity ofa Malaria Invasion Receptor
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Figure 6. Effects of carbohydrate presentation on the binding of
EBA-175 to erythrocytes. Binding assays were conducted with
[3H]isoleucine-labeled culture supernatants as described in Mate-
rials and Methods in the presence of increasing concentrations of
glycophorin A (o), fetuin (o), and Neu5Ac(a2-3) lactose (A). Af-
ter separation by SDS-PAGE and detection by fluorography, bind-
ing was quantified by scanning densitometry ofthe autoradiographs
and the inhibition was expressed as a percentage of control binding
as described in Materials and Methods.
Neu5Ac(c12-3)Lac are inhibitory at similar effective Neu5Ac-
(a2-3)Gal- concentrations. This suggests that the tetrasac-
charides of fetuin are acting independently ofeach other due
to their distal spatial distribution on the polypeptide back-
bone and therefore behave similar to free Neu5Ac(ca2-3)Lac
monomers in solution. Conversely, glycophorin A contains
11 tetrasaccharide units within the first 30 amino acids. The
clustering of these units at the amino terminus of the glyco-
phorin A dimer may provide for the higher affinity binding
of EBA-175 which cannot be mimicked by either Neu5Ac-
(a2-3)Lac or the three individual tetrasaccharide units of
fetuin. Peptide sequence may also contribute to some degree
in binding efficiency and is currently under investigation.
Similar fine specificity has been described for binding of
the hemagglutinin glycoprotein of influenza virus used for
tissue-specific viral endocytosis into host cells. In compar-
ing the binding activities of these lectin-like pathogen recep-
tors, neither activity is effectively diminishedin the presence
of free Neu5Ac (15) ; however, both EBA-175 and influenza
A and B viral hemagglutinins recognize a more complex
ligand, specific for composition and anomeric linkage. For
the much-studied viral hemagglutinin, strains have been iso-
Table 111. Inhibition of EBA-175 Binding to Erythrocytes with NeuAc(a2-3)Gal- and Neu&(a2-6)
Gal-containing Oligosaccharides
25
0 `-e ,--a
0.0001 0.01 1 .0 100
Effective NeuAc(a2,3)Gal- Ccncentration (mM)
" The final concentrations of all oligosaccharides tested were 50 mM and the culture supernatants were adjusted to pH 7.0 before mixing with erythrocytes.
t Binding assays were conducted as described in Materials and Methods. EBA-175 binding was quantified by scanning laser densitometry of fluorographs using
an LKB 2022 Ultrascan laser densitometer. Relative binding inhibition is expressed as a percentage of control binding.
Oligosaccharide addition" Structure Percent inhibition$
No additions 0
LST a Neu5Aca2-3Galo1-3G1cNAco l-3Galß1-4Glc 85.6
LST b GalOl-3G1cNAcO1-3GalO1-4Glc 49.6
1(a2-6)
Neu5Ac
DST Neu5Aca2-3GalO1-3G1cNAco 1-3Galol-4Glc 88.5
1(a2-6)
Neu5AcTable IV. Effects ofPeriodate OxidationIBorohydride
Reduction ofIntact Erythrocytes on the Binding ofEBA-175
* Intact erythrocytes were treated with NaI04 at the indicated concentrations
and reduced with NaBH4 (1 mg ml-1) as described in Materials and Methods.
Control erythrocytes were treated in buffer only or reduced with NaBH4 only
where indicated.
t Binding assays were conducted as described in Materials and Methods using
1 x 109 erythrocytes and 0.1 ml culture supernatant (1 .5 x 10' schizont
equivalents ml-') . Relative binding of EBA-175 was quantified by scanning
laser densitometry of fluorographs using an LKB 2022 Ultrascan laser den-
sitometer and are reported as a measure of control binding.
lated that preferentially bind to oligosaccharides terminating
in Neu5Ac(a2-6)Gal- sequences, whereas other isolates re-
quire the Neu5Ac(a2-3)Gal- sequences (45, 46). The two- to
threefold differences in binding affinities exhibited by these
hemagglutinins with respect to the linkage ofterminal Neu-
5Ac have been attributed to a single amino acid change at the
binding site (45, 46) . X-ray crystallography of the binding
site of influenza hemagglutinin (44) also suggests that bulky
substitutions at the terminal Neu5Ac(a2-3)-residue may pre-
cludebinding. Influenza A and B hemagglutinins do not effec-
tively bind to acetylated derivatives of the exocyclic side
chain such as in 9-O-Neu5Ac (20). Influenza C hemaggluti-
nins, however, utilize 9-O-Neu5Ac acid as an essential com-
ponent of the cell surface receptor (39) . In comparison,
EBA-175 cannot bind to this Neu5Ac derivative. Efficiency
of binding and merozoite invasion were both found to be in-
versely related with the levels of the 9-0-acetyl derivative on
the mouse erythrocyte surface (24) . Enzymatic removal of
the bulky O-acetyl moiety at the C-9 position increased
EBA-175 binding with a similar increase in invasion ofmouse
erythrocytes by Plasmodiumfalciparum merozoites.
In contrast to the sensitivity of binding to the Neu5Ac-Gal
linkage and 9-O-acetylation, removal of the exocyclic side
chain had no appreciable effect on the binding of EBA-175.
The binding activity of EBA-175 was effectively unchanged
afterperiodate oxidation and borohydride reduction of intact
erythrocytes, conditions specific for external sialic acid-
containing glycoproteins (42) (Table IV) . This suggested that
binding specificity is primarily dependent on linkage and
anomeric configuration. Derivitization at sites on the exo-
cyclic side chain may preclude binding due to an imperfect
fit in the binding pocket.
During invasion, it has been postulated that there are sev-
eral parasite-derived proteins that interact with glycophorin
A on the erythrocyte surface during the sequential processes
of merozoite invasion. Attachment to and interaction of a
lectin-like protein, such as EBA175, to the oligosaccharides
of glycophorin A, may allow the subsequent exposure of and
binding to the polypeptide domain ofglycophorin A near the
lipidinterface by EBA-175 or by other proteins. Several stud-
ies have reported the binding ofother malaria antigens to im-
mobilized glycophorin A and glycophorin peptides (10, 22,
23, 37). It has also been suggested that Gp195 is a putative
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sialic acid-binding protein which interacts weakly with gly-
cophorin A on erythrocytes (38) . The nature of this binding
and the ligand specificity have not been thoroughly reported .
As demonstrated in this study, EBA-175 in its interaction
with the O-linked tetrasaccharide clusters of glycophorin A
forms a highly specific receptor-ligand complex with the
erythrocyte. Further studies may determine whether EBA-
175 has multiple binding sitesper molecule or whether EBA-
175 molecules associate as multimers in their binding to
the tetrasaccharide~clusters of glycophorin A. Through self-
association or in concert with other malaria proteins, EBA-
175 appears to be an essential component in sialic acid-
dependent malaria invasion.
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Note Addedin Proof. In supportofthe directcorrelation between EBA-175
binding and parasite invasion, we have obtained additional evidence that
(a2-3)-linked Neu5Ac is required for optimal invasion by treating intact
erythrocytes with NDV (6 1~g ml- I NDV in RPMI medium, pH 6.7, 1 h,
37*C and erythrocytes at 1 % Hct). Invasion by Camp strain parasites into
washed, treated erythrocytes was significantly decreased (to 10% of that
into control, untreated erythrocytes). In anothercontrol to show that NDV
treatment did not render the erythrocytes refractory to invasion in a non-
specific manner, it was found that invasion by 7G8 strain parasites, which
additionally possess a sialic acid-independent invasion pathway, into
washed, treated erythrocytes was, as expected (20), much less effected
(61 % of untreated controls).
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